These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 3979949)
1. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Serri O; Renier G; Somma M Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949 [TBL] [Abstract][Full Text] [Related]
2. [3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland. Stefanini E; Devoto P; Marchisio AM; Vernaleone F; Collu R Life Sci; 1980 Feb; 26(8):583-7. PubMed ID: 7382736 [No Abstract] [Full Text] [Related]
3. Dopamine receptor binding is increased in diabetic rats. Lozovsky D; Saller CF; Kopin IJ Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088 [TBL] [Abstract][Full Text] [Related]
4. Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland. Lightman SL; Ninkovic M; Hunt SP Neurosci Lett; 1982 Oct; 32(2):99-102. PubMed ID: 7145239 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex. Marchais D; Tassin JP; Bockaert J Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406 [No Abstract] [Full Text] [Related]
6. Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats. Pilotte NS; Burt DR; Barraclough CA Endocrinology; 1984 Jun; 114(6):2306-11. PubMed ID: 6723585 [TBL] [Abstract][Full Text] [Related]
7. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol. Hancock AA; Marsh CL Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230 [TBL] [Abstract][Full Text] [Related]
8. Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain. Di Paolo T; Carmichael R; Labrie F; Raynaud JP Mol Cell Endocrinol; 1979 Nov; 16(2):99-112. PubMed ID: 116893 [TBL] [Abstract][Full Text] [Related]
9. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Bennett JP; Wooten GF Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090 [TBL] [Abstract][Full Text] [Related]
10. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics. Nakajima T; Egawa E; Kuruma I Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446 [TBL] [Abstract][Full Text] [Related]
11. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication. Van der Werf JF; Van het Schip F; Sebens JB; Korf J Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037 [TBL] [Abstract][Full Text] [Related]
13. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites. Coupet J; Rauh CE Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420 [TBL] [Abstract][Full Text] [Related]
14. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors. Tachizawa H; Sudo K; Sano M Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256 [TBL] [Abstract][Full Text] [Related]
15. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum. Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097 [TBL] [Abstract][Full Text] [Related]
16. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions? Clements-Jewery S; Robson PA Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304 [No Abstract] [Full Text] [Related]
17. Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion. Meltzer HY; So R; Miller RJ; Fang VS Life Sci; 1979 Aug; 25(7):573-83. PubMed ID: 41148 [No Abstract] [Full Text] [Related]
18. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes. Howlett DR; Nahorski SR FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328 [No Abstract] [Full Text] [Related]
19. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum. Korf J; Sebens JB; Flentge F; van der Werf JF J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835 [TBL] [Abstract][Full Text] [Related]
20. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase. Bhargava HN Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]